Skip to main content
Top
Published in:

Open Access 01-12-2017 | Letter to the Editor

Zinc and curcumin lower arylsulfatses and some metabolic parameters in streptozotocin-induced diabetes

Authors: Mahmoud Balbaa, Marwa El-Zeftawy, Nabil Taha, Abdel-Wahab Mandour

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2017

Login to get access

Abstract

In rats with induced diabetes, Zinc and curcumin treatment showed a significant increase of catalase and a significant decrease of glucose, lipid profile components and arylsulphatases activity compared to the untreated rats. We suggest that dietary zinc and curcumin are promising protective agents for reducing the metabolic defect of diabetes.
Literature
1.
go back to reference Firoozrai M, Nourbakhsh M, Razzaghy-Azar M. Erythrocyte susceptibility to oxidative stress and antioxidant status in patients with type 1 diabetes. Diabetes Res Clin Pract. 2007;77:427–32.CrossRefPubMed Firoozrai M, Nourbakhsh M, Razzaghy-Azar M. Erythrocyte susceptibility to oxidative stress and antioxidant status in patients with type 1 diabetes. Diabetes Res Clin Pract. 2007;77:427–32.CrossRefPubMed
2.
go back to reference Joe B, Vijaykumar M, Lokesh BR. Biolgical properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr. 2009;44:97–111.CrossRef Joe B, Vijaykumar M, Lokesh BR. Biolgical properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr. 2009;44:97–111.CrossRef
3.
go back to reference Best L, Elliott AC, Brown PD. Curcumin induces electrical activity in rat pancreatic beta-cells by activating the volume-regulated anion channel. Biochem Pharmacol. 2007;73:1768–75.CrossRefPubMed Best L, Elliott AC, Brown PD. Curcumin induces electrical activity in rat pancreatic beta-cells by activating the volume-regulated anion channel. Biochem Pharmacol. 2007;73:1768–75.CrossRefPubMed
4.
go back to reference Jansen J, Karges W, Rink L. Zinc and diabetes- clinical links and molecular mechanisms. J Nutr Biochem. 2009;20:399–417.CrossRefPubMed Jansen J, Karges W, Rink L. Zinc and diabetes- clinical links and molecular mechanisms. J Nutr Biochem. 2009;20:399–417.CrossRefPubMed
7.
go back to reference Doumas BT, Bayse DD, Carter R, Peters Jr T, Schaffer R. A candidate reference method for determination of total protein in serum. I. Development and validation. Clin Chem. 1981;27:1642–50.PubMed Doumas BT, Bayse DD, Carter R, Peters Jr T, Schaffer R. A candidate reference method for determination of total protein in serum. I. Development and validation. Clin Chem. 1981;27:1642–50.PubMed
8.
go back to reference Balbaa M, El-Kersh M, Mansour H, Yacout G, Ismail M, Malky A, Bassiouny K, Abdel-Monem N, Kandeel K. Activity of some hepatic enzymes in schistosomiasis and concomitant alteration of arylsulfatase B. J Biochem Mol Biol. 2004;37:223–28.PubMed Balbaa M, El-Kersh M, Mansour H, Yacout G, Ismail M, Malky A, Bassiouny K, Abdel-Monem N, Kandeel K. Activity of some hepatic enzymes in schistosomiasis and concomitant alteration of arylsulfatase B. J Biochem Mol Biol. 2004;37:223–28.PubMed
10.
go back to reference Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:476–82.PubMed Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:476–82.PubMed
11.
go back to reference Burestein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970;11:583–93. Burestein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970;11:583–93.
12.
go back to reference Prasad AS. Clinical, immunological, anti-inflammatory and anti-oxidant roles of zinc. Exp Gerontol. 2008;43:370–77.CrossRefPubMed Prasad AS. Clinical, immunological, anti-inflammatory and anti-oxidant roles of zinc. Exp Gerontol. 2008;43:370–77.CrossRefPubMed
13.
Metadata
Title
Zinc and curcumin lower arylsulfatses and some metabolic parameters in streptozotocin-induced diabetes
Authors
Mahmoud Balbaa
Marwa El-Zeftawy
Nabil Taha
Abdel-Wahab Mandour
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2017
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1186/s40200-017-0293-7

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more